{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:53:59Z","timestamp":1770144839123,"version":"3.49.0"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":968,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1999,5]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Testosterone (T) substitution of hypogonadal men by conventional intramuscular injection of T esters is not considered optimal because it induces unphysiologically fluctuating serum T levels. In contrast, scrotal T patches produce normal serum (T) levels mimicking diurnal variations. In order to assess the quality of this new form of T substitution we followed hypogonadal men treated by transdermal T up to 10 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS<\/jats:title><jats:p>Eleven men aged 35.9\u2003\u00b1\u20039.8 years (mean \u00b1\u2003SD) at the beginning of the study were treated with transscrotal T patches (Testoderm<jats:sup>\u00ae<\/jats:sup>) because of primary (<jats:italic>n<\/jats:italic>\u2003=\u20034) or secondary (<jats:italic>n<\/jats:italic>\u2003=\u20037) hypogonadism. Clinical examinations were performed every 3 months during the first 5 years and every 6 months thereafter. All 11 patients were seen for 7 years and some for longer periods: eight for 8 years, six for 9 years and four for 10 years.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS AND RESULTS<\/jats:title><jats:p>With daily application of one patch T levels rose from 5.3\u2003\u00b1\u20031.3\u2003nmol\/l (mean\u2003\u00b1\u2003SE) to 16.7\u2003\u00b1\u20032.6\u2003nmol\/l at month 3 and remained in the normal range throughout treatment. Serum 5\u03b1\u2010dihydrotestosterone (DHT) rose from 1.3\u2003\u00b1 0.4\u2003nmol\/l to 3.9\u2003\u00b1\u20031.4\u2003nmol\/l and oestradiol from 52.3\u2003\u00b1\u20039.3 to 71.3\u2003\u00b1\u20039.6\u2003pmol\/l and remained stable without significant variations throughout the observation period. Patients reported absence of local side\u2010effects except for occasional itching. No relevant changes occurred in clinical chemistry, including total cholesterol levels and triglycerides. Haemoglobin and erythrocyte counts remained normal. Bone density measured by QCT increased slightly from 113.6\u2003\u00b1 5.4 to 129.7\u2003\u00b1\u20039.3\u2003mg\/cm<jats:sup>3<\/jats:sup> during the observation period (<jats:italic>P<\/jats:italic>\u2003=\u20030.028). In the nine patients aged &lt;\u200350 years prostate volumes showed a small but insignificant increase from 16.8\u2003\u00b1\u20031.5 to 18.8\u2003\u00b1\u20032.1\u2003ml during transscrotal T therapy. In the two older patients prostate volume remained constant or decreased slightly during T therapy after an initial increase in the previously untreated patient. Prostate specific antigen levels were constantly low in all patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>Transscrotal testosterone patches are well\u2010accepted and safe in long\u2010term testosterone substitution therapy for male hypogonadism.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1999.00705.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:41:07Z","timestamp":1047379267000},"page":"629-635","source":"Crossref","is-referenced-by-count":96,"title":["Long\u2010term substitution therapy of hypogonadal men with transscrotal testosterone over 7\u201310 years"],"prefix":"10.1111","volume":"50","author":[{"given":"Hermann M.","family":"Behre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Von Eckardstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Kliesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Nieschlag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.3071113.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)90600-8"},{"key":"e_1_2_6_4_2","first-page":"7","article-title":"Substitution therapy of hypogonadal men with transdermal testosterone over one year","volume":"118","author":"Bals\u2010Pratsch M.","year":"1988","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb03929.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/jcem.82.8.4163","article-title":"Long\u2010term effect of testosterone therapy on bone mineral density in hypogonadal men","volume":"82","author":"Behre H.M.","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"e_1_2_6_7_2","first-page":"27","article-title":"Clinical relevance of scrotal and transrectal ultrasonography in andrological patients","volume":"18","author":"Behre H.M.","year":"1995","journal-title":"International Journal of Andrology"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","unstructured":"Behre H.M.&Nieschlag E.(1998) Comparative pharmacokinetics of testosterone esters. In:Testosterone: Action Deficiency Substitution(eds E. Nieschlag & H.M. Behre) 2nd edn. pp.329348. Springer Heidelberg.","DOI":"10.1007\/978-3-642-72185-4"},{"key":"e_1_2_6_9_2","first-page":"929","article-title":"Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis","volume":"25","author":"Bronson W.D.","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1992.tb00319.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.1992.03480160073037","article-title":"Longitudinal evaluation of prostate\u2010specific antigen levels in men with an without prostate disease","volume":"267","author":"Carter H.B.","year":"1992","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_6_12_2","first-page":"184","article-title":"Longitudinal evaluation of prostate\u2010specific antigen levels in a case\u2013control study","volume":"29","author":"De Biasi F.","year":"1996","journal-title":"European Urology"},{"key":"e_1_2_6_13_2","first-page":"652","article-title":"Transdermal testosterone","volume":"1","author":"Editorial","year":"1989","journal-title":"Lancet"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-2-266"},{"key":"e_1_2_6_15_2","unstructured":"Finkelstein J.S.(1998) Androgens and bone metabolism. In:Testosterone: Action Deficiency Substitution(eds E. Nieschlag & H.M. Behre) 2nd edn pp.187207. Springer Heidelberg."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1994.tb00433.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1210\/jcem.82.11.4387","article-title":"Outcomes of long\u2010term testosterone replacement in older hypogonadal males: a retrospective analysis","volume":"82","author":"Hajjar R.R.","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1046-199X(97)90003-8"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","unstructured":"Krieg M.&Tunn S.(1990) Androgens and human benign prostatic hyperplasia (BPH). In:Testosterone: Action Deficiency Substitution(eds E. Nieschlag & H.M. Behre) pp.219244. Springer Heidelberg.","DOI":"10.1007\/978-3-662-00814-0_12"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1380051"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","unstructured":"Meikle W.A.(1998) A permeation\u2010enhanced non\u2010scrotal testosterone transdermal system for the treatment of male hypogonadism. In:Testosterone: Action Deficiency Substitution(eds E. Nieschlag & H.M. Behre) 2nd edn. pp.389422. Springer Heidelberg.","DOI":"10.1007\/978-3-642-72185-4_14"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00445-1"},{"key":"e_1_2_6_23_2","unstructured":"Nieschlag E. Wang C. Handelsman D.J. Swerdloff R.S. Wu F. Einer\u2010Jensen N. Waites G.(1992)Guidelines for the Use of Androgens. WHO Geneva."},{"key":"e_1_2_6_24_2","doi-asserted-by":"crossref","unstructured":"Nieschlag E.&Behre H.M.(1998) Pharmacology and clinical uses of testosterone. In:Testosterone: Action Deficiency Substitution(eds E. Nieschlag & H.M. Behre) 2nd edn pp.293328. Springer Heidelberg.","DOI":"10.1007\/978-3-642-72185-4"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.10.3443"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.6.3988"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-5122(85)90051-9"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1999.00705.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1999.00705.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1999.00705.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T20:26:04Z","timestamp":1698524764000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1999.00705.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["10.1046\/j.1365-2265.1999.00705.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1999.00705.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}